Displaying 1 - 6 of 6
  • Print
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
40 1171V ALDOMET 250MG TAB (ASG/STO) METHYLDOPA METHYLDOPA ALDOMET 30'S A 5.44 0.18 TABLET 180 TAB ASG ASPEN OSD (GLOBAL) STO BRYDEN STOKES LTD B 240816 CENTRAL ALPHA ANTAGONIST 2022-04-01 2024-03-31 Oral 6 CARDIOVASCULAR DRUGS
41 1171V ALDOMET 250MG TAB (ASG) METHYLDOPA METHYLDOPA ALDOMET 30'S A 11.63 0.3878 TAB 180 BOX ASG ASPEN OSD (GLOBAL) STO BRYDEN STOKES LTD B 240816 CENTRAL ALPHA ANTAGONIST 2024-04-01 2026-03-31 ORAL 6 CENTRAL ALPHA ANTAGONIST
42 1171V ALDOMET 250MG TAB (ASG) METHYLDOPA METHYLDOPA ALDOMET 30'S A 13.65 0.46 TAB 180 BLIS ASG ASPEN OSD (GLOBAL) STO BRYDEN STOKES LTD B 240816 CENTRAL ALPHA ANTAGONIST 2026-04-01 ORAL 6 CENTRAL ALPHA ANTAGONIST
40 1172K ALDOMET 500MG TAB (ASG/STO) METHYLDOPA METHYLDOPA ALDOMET 30'S A 8.83 0.29 TABLET 180 TAB ASG ASPEN OSD (GLOBAL) STO BRYDEN STOKES LTD B 240816 CENTRAL ALPHA ANTAGONIST 2022-04-01 2024-03-31 Oral 6 CARDIOVASCULAR DRUGS
41 1172K ALDOMET 500MG TAB (ASG) METHYLDOPA METHYLDOPA ALDOMET 30'S A 19.03 0.6343 TAB 180 BOX ASG ASPEN OSD (GLOBAL) STO BRYDEN STOKES LTD B 240816 CENTRAL ALPHA ANTAGONIST 2024-04-01 2026-03-31 ORAL 6 CENTRAL ALPHA ANTAGONIST
42 1172K ALDOMET 500MG TAB (ASG) METHYLDOPA METHYLDOPA ALDOMET 30'S A 22.32 0.74 TAB 180 BLIS ASG ASPEN OSD (GLOBAL) STO BRYDEN STOKES LTD B 240816 CENTRAL ALPHA ANTAGONIST 2026-04-01 ORAL 6 CENTRAL ALPHA ANTAGONIST